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1. INTRODUCTION 
The cytochrome b-cl [ 1,2] complex corresponds 
to the second coupling side of the mitochondrial 
respiratory chain and functions as a redox proton 
pump [2-71. The mechanism by which reducing 
equivalents enter the complex and are transferred 
to cytochrome c is, as yet, not fully understood 
[1,6-121. Definite contributions towards these 
problems come from the use of specific inhibitors. 
Antimycin inhibits electron flow between the b- 
cytochromes and cytochrome ct [ 131, and probably 
binds to the apoprotein of b-cytochromes [2,14] 
close to the heme b562 [13]. It promotes also oxi- 
dant-induced reduction of b-cytochromes [ 151 and, 
under particular conditions, inhibits reduction of 
b-cytochromes by substrates [ 10,12,16]. These and 
related observations have led to the view that elec- 
tron flow in the b-cl complex takes place through 
branched [8,15] or cyclic pathways [6,7,10-121 
rather than by linear sequence. 
It has been proposed that quinone analogues 
like DBMIB (2,5-dibromo-3-methyl-6-isopropyl- 
benzoquinone) and UHDBT inhibit the b-cl com- 
plex by disturbing the redox activity of the FeS- 
protein g = 1.90 of the complex [ 16,2 11. 
Here we describe a stopped-flow kinetic analysis 
of the action of the hydroxyquinoline derivative 
HQNO and of UHDBT on redox as well as pro- 
tonmotive activity of the b-cl complex. The re- 
sults provide information on the sites of action of 
these inhibitors and the role of the complex in re- 
dox-linked proton translocation by the cytochrome 
chain. 
2. MATERIALS AND METHODS 
Alkyl hydroxyquinoline derivatives and quinone 
analogues are other interesting inhibitors of the b- 
cl complex. Hydroxyquinoline derivatives exert a 
twofold action on the complex. These compounds, 
besides displaying an inhibitory action similar to 
that of antimycin [1,13,17,18], appear to exert a 
second inhibitory effect on redox component(s) of 
the b-cl complex [ 19,201. 
Valinomycin, oligomycin, antimycin A and 
HQNO were obtained from Sigma Chemical Co. 
UHDBT was prepared as described in [21]. All the 
other reagents were of the highest purity grade 
available. 
Abbreviations: 2-Heptyl-4-hydroxyquinoline-N-oxide, 
HQNO; 5-(n-undecyl)-6-hydroxyl-4,7-dioxobenzothia- 
zole, UHDBT. 
Heavy beef-heart mitochondria were prepared 
as in [22]. Oxidoreduction of cytochromes was 
monitored with a Johnson Foundation dual wave- 
length spectrophotometer quipped with regenera- 
tive stopped flow apparatus. The mixing ratio was 
1:62, the reaction time during the continuous-flow 
phase was 12 ms (for details see [4]). Proton trans- 
location was measured with a Roughton-type, re- 
petitive, continuous-flow pH-meter (mixing ratio 
1:60). For details see [4,23]. 
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3. RESULTS AND DISCUSSION 
In fig.1 a stopped-flow analysis is presented of 
the effect of inhibitors of the b-cl complex on re- 
dox transitions of b and c cytochromes elicited by 
starts 
b 
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Fig.1. Effect of UHDBT, antimycin A and HQNO on 
the kinetics of aerobic redox transitions of cytochromes 
in beef-heart mitochondria. Mitochondria (2 mg pro- 
tein . ml- t) were incubated in the main-syringe of the 
flow-apparatus at 25°C in: 200 mM sucrose, 20 mM 
KCI, 3.5 mM succinate, 0.5 pclg valinomycin . mg pro- 
tein- I, 0.5 pg rotenone. mg protein- 1 and 2 pg oligo- 
mycin . mg protein- 1. pH 7.2. The system became an- 
aerobic due to succinate reduction of respiratory 
carriers. Then 3.5 mM K-malonate was added. Oxygen 
was delivered from the side-syringe of the flow-appara- 
tus as: 200 mM sucrose and 30 mM KCl. (a), control; 
(b), 5 nmol UHDBT . mg protein- I; (c) 0.5 nmol anti- 
mycin . mg protein- 1; (d) 5 nmol HQNO . mg pro- 
tein pt. The number on the traces refer to the t ~1~ of b- 
cytochrome oxidation or reduction and c-cytochromes 
oxidation. All the f ,h are given in ms except those of ox- 
idation of b-cytochromes in presence of UHDBT, which 
1 2 3 4 5 
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Fig.2. Titration of the inhibition by UHDBT of aerobic 
oxidation of b-cytochromes in beef-heart mitochondria. 
For experimental conditions see legend to fig.1. 
Mitochondria were incubated with UHDBT 5 min in 
are given in seconds. anaerobiosis. 
rapid oxygenation of anaerobic beef-heart mito- 
chondria whose respiratory carriers had been re- 
duced by succinate. Malonate was added to inhibit 
re-reduction of respiratory carriers oxidized by 
oxygen. Oxygenation caused, after a lag of 12 ms, 
net oxidation of b-cytochromes (fig.la) [9,24]. 
Antimycin (figlc) changed the response of b- 
cytochromes to oxygenation from net oxidation to 
net extra-reduction [9,24]. HQNO (fig.ld) mim- 
icked in this respect antimycin. It should, however, 
be noted that the ty2 for the HQNO promoted re- 
duction of b-cytochromes was significantly higher 
than the ty2 for the antimycin-promoted reduction. 
UHDBT (fig.1 b) behaved differently from the 
other two inhibitors. In fact, it simply depressed 
the rate of aerobic oxidation of 6-cytochromes 
without causing net extra-reduction. 50% inhibi- 
tion by UHDBT of cytochrome b oxidation was 
caused by 0.5 nmol/mg protein (fig.2). All the 
three inhibitors enhanced the net rate of aerobic 
oxidation of c-cytochromes. 
The above experiments show that, whilst HQNO 
exerts an antimycin-like effect on the b-cl com- 
plex, UHDBT acts differently. It may be recalled 
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Fig.3. Effect of UHDBT and HQNO on redox transi- 
tions of cytochromes induced by oxygen pulses of an- 
aerobic antimycin A treated beef-heart mitochondria. 
The experimental conditions were those described in the 
legend to fig.1 except that 0.5 nmol antimycin A. mg 
protein- 1 was present. Further additions: (a) none; (b) 
1 nmol UHDBT . mg protein- *; (c) 2 nmol HQNO . mg 
protein- I; (d) 1 nmol UHDBT. mg protein- I + 2 
nmol HQNO . mg protein- I. 
that the concentrations of the three inhibitors used 
in the experiments of fig.1 depressed to the same 
extent (95%) the respiratory activity of mito- 
chondria with succinate as substrate (see 
[13,18,21]). 
Figure 3 illustrates the effect of HQNO and 
UHDBT on the kinetics of antimycin-promoted 
oxygen-induced reduction of b-cytochromes. 
Either HQNO or UHDBT caused a significant de- 
pression of the rate of cytochrome b-reduction. 
Furthermore the inhibitory effects of UHDBT and 
HQNO were additive. These experiments show 
that HQNO, in addition to the antimycin like in- 
hibitory effect documented in fig. 1, exerts a second 
distinct inhibitory effect. This latter inhibitory 
effect is analogous to that caused by UHDBT and 
is apparently exerted, as shown by the additivity of 
inhibition, at the same site of action of UHDBT. 
It has been reported that rapid aerobic oxidation 
of terminal respiratory carriers in antimycin-in- 
hibited mitochondria supplemented with inhibi- 
tors of dehydrogenases and valinomycin (plus K+) 
results in synchronous proton release [3,8,25,26]. It
is disputed whether this proton ejection results 
simply from antimycin-insensitive residual oxida- 
tion of hydrogenated carriers on the substrate side 
of cytochrome c [8,9,25,26] or if it reflects also a 
proton pumping activity of cytochrome c oxidase 
1271. 
Figure 4 shows that the rapid proton ejection ac- 
companying the aerobic oxidation of c cytochromes 
and reduction of b cytochromes was inhibited by 
both HQNO and UHDBT. Also these inhibitory 
effects of UHDBT and HQNO were additive. 
The H+/e- stoicheiometry for experiments as 
those presented in figs. 3 and 4 are reported in 
table 1. The total amount of electron flow to oxy- 
gen was obtained by summing up the nmoles of 
hemes a and a3 oxidized and the equivalent 
amount of copper atoms, the nmoles of cyto- 
chromes c + cl and of the FeS-protein of the b-cl 
0 50 100 
time 
(msec) 
Fig.4. Effect of UHDBT and HQNO on H+ release in- 
duced by oxygen pulses of anaerobic antimycin treated 
beef-heart mitochondria. For experimental procedure 
see Materials and Methods. For experimental conditions 
see legend to tig.3. Symbols: (0-a) control; (A-&) 1 
nmol UHDBT . mg protein- I; (0-0) 2 nmol 
HQNO . mg protein- I; (A-.) 1 nmol UHDBT. mg 
protein- I + 2 nmol HQNO . mg protein- I. 
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Table 1 
Stoicheiometry of oxidation of redox carriers and H+ release 
caused by oxygen pulses of anaerobic antimycin-inhibited beef- 
heart mitochondria. Effect of UHDBT and HQNO 
50 ms 
(a) (b) (c) (d) 
H + released 
(ng-ions . mg protein-t) 
1.60 1.02 0.82 0.60 
Respiratory carriers oxidized a+a3 0.80 0.81 0.81 0.80 
(nmol . mg protein-l) cu 0.80 0.81 0.81 0.80 
c+cI 0.56 0.60 0.60 0.51 
FeS 0.28 0.30 0.30 0.29 
e- equivalent to cyt. b reduced 0.16 0.10 0.15 0.09 
Ce- flow 2.60 2.62 2.67 2.55 
H+ /Ze- 0.61 0.39 0.31 0.23 
For experimental conditions see legends to figs. 3 and 4. The 
values reported above refer to 50 ms after oxygenation. The 
nmoles of hemes a+a3 were calculated with a AemM of 14 1281. 
The atoms of copper oxidized were taken as equivalent to nmoles 
of hemes a+as oxidized (291. The nmoles of c-cytochromes were 
calcualted with a AE,,,M of 19.1 from the absorbance changes at 
550-540 nm 1301. The nmoles of FeS-protein g = 1.90 were taken 
as equivalent to % the amount of c-cytochromes oxidized. The 
nmoles of b-cytochromes reduced were calculated with a AemM of 
20 1311 from the absorbance changes at 562-575 nm (see text). 
Further additions: Expt. (a), none; expt. (b), 1 nmol UHDBT . mg 
protein- I; expt. (c), 2 nmol HQNO. mg protein 1; expt. (d), 1 
nmol UHDBT. mg protein- i and 2 nmol HQNO . mg protein- 1. 
complex oxidized, the latter is taken as equivalent 
to half the amount of c-cytochromes oxidized. 
Since the aerobic reduction of b-cytochromes is 
generally thought as being produced by antimycin- 
insensitive oxidation of quinol to semiquinone [6- 
8,161 the sum of electron flow included also an 
amount of electrons equivalent to the nmoles of b- 
cytochromes reduced. This may, however, repre- 
sent a minimum estimate of the amount of quinol 
actually oxidized (see [24]). 
The H+ /e- ratio in the absence of other inhibi- 
tors but in the presence of antimycin amounted to 
0.6 which is practically half the value expected in 
the case where oxidase pumped H+ in the 
medium at a stoicheiometry of 1 H+ per e- [7]. 
HQNO or UHDBT decreased the H+ /e- ratio. In 
the presence of UHDBT and HQNO added to- 
gether, the H+ /e- ratio was lower than that found 
with either of the two inhibitors added alone; it 
amounted only to 0.2. 
It should be noted that UHDBT and HQNO at 
the concentrations used in the experiments of table 
1 do not exert any signScant protonophoric ac- 
tivity (21,32,33]. It has, in fact, been shown that 
even FCCP, at concentrations displaying maximal 
protonophoric activity in coupling membranes, is 
ineffective on rapid H + transfer reactions associ- 
ated to fast redox transitions of respiratory carriers 
which take place in a millisecond time scale [34]. 
On the basis of the results presented, which are 
consistent either with a branched [8,15] or a cyclic 
mechanism of electron transfer by the b-cl com- 
plex [6,7,10-121, we draw the following con- 
clusions (see also [8]). 
1. Antimycin and UHDBT exert their inhibitory 
effects at two different sites of the b-cl complex: 
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the former inhibits electron transfer from 
cytochrome b562 [6,8] to a protein bound quinone 
(semiquinone) system [35,36] probably associated 
to the FeS-protein of the complex [16]. UHDBT 
acts by blocking the redox activity of the FeS-pro- 
tein, possibly inhibiting oxidation of bound ubi- 
quinol by the FeS-protein [ 161. 
2. HQNO exerts a twofold inhibitory effect on 
the complex [ 19,201. A predominant antimycin-like 
inhibitory effect at the same inhibition site 
[ 13,17,18,20] and an apparently weaker inhibitory 
effect [20] similar and at the same inhibition site of 
UHDBT. Evidence has in fact been presented that 
UHDBT and nonyl-4-hydroxyquinoline-N-oxide 
compete for a common binding site in the b-cl 
complex [37]. 
3. The rapid ejection of protons observed upon 
aerobic oxidation of the reduced cytochrome chain 
in antimycin (and valinomycin) treated mito- 
chondria derives from electron flow in the b-cl 
complex [25,26]. In fact inhibition of antimycin-in- 
sensitive electron flow in the b-cl complex by 
UHDBT and HQNO suppresses almost com- 
pletely the proton release. The residual H+ release 
is not higher than the scalar proton release which 
may arise from redox Bohr effects in cytochrome c 
oxidase and the FeS-protein which can amount, at 
pH 7.2, to 0.9 and 0.8 equivalent H+ per hemes 
a+a3 and FeS protein undergoing oxidation [38]. 
It seems that under the conditions of a single turn- 
over there is no sign of a proton pumping activity 
of cytochrome c oxidase (compare [8,25,26,33,39]; 
contrast [7,27]). 
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